S&P Biotech SPDR ETF
XBI
$0.17 (-0.14%)
1D
1W
3M
1Y
5Y
ALL
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 16 days ago • XBI
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)?
Zacks Investment Research • about a month ago • XBI
Biotech ETF (XBI) Hits New 52-Week High
Seeking Alpha • about a month ago • XBI
BBH: Mature Biotech Exposure, But Limited Growth Ahead
WSJ • about 2 months ago • XBI
Funding for Risky Biotechs Is Returning
CNBC Television • about 2 months ago • XBI
Mizuho's Jared Holz on what biotech dealmaking looks like in 2026
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.